Catherine Schulte
Stock Analyst at Baird
(4.68)
# 136
Out of 4,479 analysts
81
Total ratings
64.37%
Success rate
18%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $147 → $136 | $125.78 | +8.13% | 11 | May 30, 2024 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,212 → $1,360 | $1,357.07 | +0.22% | 5 | May 13, 2024 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $8 → $10 | $6.84 | +46.20% | 3 | May 9, 2024 | |
| TECH Bio-Techne | Maintains: Outperform | $73 → $81 | $71.24 | +13.70% | 3 | May 2, 2024 | |
| AVTR Avantor | Maintains: Outperform | $27 → $26 | $20.58 | +26.34% | 8 | Apr 29, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $621 → $620 | $533.93 | +16.12% | 20 | Apr 25, 2024 | |
| DHR Danaher | Maintains: Outperform | $259 → $271 | $240.41 | +12.72% | 4 | Apr 24, 2024 | |
| QGEN Qiagen | Initiates: Outperform | $52 | $40.70 | +26.54% | 1 | Sep 12, 2023 | |
| EXAS Exact Sciences | Maintains: Outperform | $99 → $121 | $43.17 | +180.29% | 10 | Aug 2, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $21.26 | +78.74% | 4 | Mar 1, 2023 | |
| TWST Twist Bioscience | Maintains: Outperform | $56 → $33 | $47.32 | -30.26% | 2 | Nov 21, 2022 | |
| ILMN Illumina | Downgrades: Neutral | n/a | $105.51 | - | 4 | Apr 21, 2020 | |
| WAT Waters | Downgrades: Neutral | n/a | $284.49 | - | 5 | Jan 24, 2019 | |
| NTRA Natera | Maintains: Outperform | n/a | $110.70 | - | 1 | Jun 28, 2018 |
Agilent Technologies
May 30, 2024
Maintains: Outperform
Price Target: $147 → $136
Current: $125.78
Upside: +8.13%
Mettler-Toledo International
May 13, 2024
Maintains: Neutral
Price Target: $1,212 → $1,360
Current: $1,357.07
Upside: +0.22%
Maravai LifeSciences Holdings
May 9, 2024
Maintains: Outperform
Price Target: $8 → $10
Current: $6.84
Upside: +46.20%
Bio-Techne
May 2, 2024
Maintains: Outperform
Price Target: $73 → $81
Current: $71.24
Upside: +13.70%
Avantor
Apr 29, 2024
Maintains: Outperform
Price Target: $27 → $26
Current: $20.58
Upside: +26.34%
Thermo Fisher
Apr 25, 2024
Maintains: Outperform
Price Target: $621 → $620
Current: $533.93
Upside: +16.12%
Danaher
Apr 24, 2024
Maintains: Outperform
Price Target: $259 → $271
Current: $240.41
Upside: +12.72%
Qiagen
Sep 12, 2023
Initiates: Outperform
Price Target: $52
Current: $40.70
Upside: +26.54%
Exact Sciences
Aug 2, 2023
Maintains: Outperform
Price Target: $99 → $121
Current: $43.17
Upside: +180.29%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $21.26
Upside: +78.74%
Twist Bioscience
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $47.32
Upside: -30.26%
Illumina
Apr 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $105.51
Upside: -
Waters
Jan 24, 2019
Downgrades: Neutral
Price Target: n/a
Current: $284.49
Upside: -
Natera
Jun 28, 2018
Maintains: Outperform
Price Target: n/a
Current: $110.70
Upside: -